Ehtisham Haider

13PUBLICATIONS
18CO-AUTHORS
Engineering electromagneticsNutrigenomics and personalised nutritionCardiology (incl. cardiovascular diseases)Pharmaceutical delivery technologiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 11, 2026
Suzetrigine (Journavx): first-in-class NaV1.8 sodium-channel blocker offering non-opioid oral relief for moderate-to-severe acute pain.

|Jun 08, 2026
Semaglutide-induced lean mass loss: clinical concern or physiological adaptation.

|Mar 07, 2026
A Critical Assessment of "Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV-Related Cirrhosis: A Landmark Analysis".

Muhammad Umer Farooq Mujahid, Ehtisham Haider

|Mar 06, 2026
Paltusotine: The first FDA approved oral treatment for acromegaly.

Bisma Faraz, Sania Sheikh, Muhammad Areeb Ul Haq

|Feb 12, 2026
Clinical significance of Zongertinib in HER2-mutated non-small cell lung cancer: advancing targeted therapy options.

Ehtisham Haider, Naveed Ahmad, Javeria Taj

|Feb 12, 2026
Avutometinib (Avmapki): oral RAF/MEK clamp inhibitor advancing precision therapy in KRAS-mutant low-grade serous ovarian cancer.

Ehtisham Haider, Yousra Anwar, Joshua Ekouo

Pageof 3

Frequent Collaborators

5 joint publications

Joshua Ekouo

3 joint publications

Naveed Ahmad

3 joint publications

Muhammad Umer Farooq Mujahid

2 joint publications

Abdullah Imtiaz